First targeted therapy available for the treatment of two main types of ANCA-associated vasculitis (AAV), a rare and systemic disease MELBOURNE, Australia, Feb. 7, 2023 /PRNewswire/ Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos in combination with a rituximab or cyclophosphamide-based regimen for the treatment of adults with anti-neutrophil cytoplasmic autoantibody (ANCA) - associated vasculitis (granulomatosis polyangiitis [GPA] or microscopic polyangiitis [MPA]); two main forms of AAV. Tavneos was granted orphan drug designation by the TGA and is the first targeted therapy for AAV and the first approved in a decade. "This is a pleasing result, and we are committed to bringing this new treatment option to Australian patients living with AAV", said James McDonnell, General Manager, CSL Vifor Australia and New Zealand. "We expect to make a submission to the Pharmaceutical Be
New Delhi [India], September 19 (ANI/NewsVoir): Housing.com, India's leading digital real estate platform, has announced the launch of its annual online real estate sales gala event, the Mega Home Utsav-2022, wherein buyers will be able to grab attractive discount offers during the virtual mega home sale from the comfort of their homes with the help of enabling technologies. Showcasing prominent properties from 22 cities in the county, the event will run between September 20 and October 20, 2022. In its 6th edition, the annual event, which coincides with the festive season, will enable homebuyers in India to get a property of their choice from a wide array of developers that have partnered with the Gurgaon-based Housing.com for the Mega Home Utsav-2022. For the event, REA India-owned Housing.com has tied up with major developers in the country who will showcase their properties during the event. The major developers that will be participating in the month-long event include G squar